
    
      To gather safety information and adverse events on the use of Gardasil® in mild to moderate
      and minimally active or inactive SLE.

      To gather information on SLE disease activity flares after vaccination with Gardasil®.

      To gather information on the immunogenicity or development of protective anti HPV antibodies
      SLE after vaccination with Gardasil®.
    
  